23
Antineoplastic Agents and Adjunct Drugs Used in Cancer Treatment

Chapter 39

  • Upload
    doria

  • View
    55

  • Download
    0

Embed Size (px)

DESCRIPTION

Antineoplastic Agents and Adjunct Drugs Used in Cancer Treatment. Chapter 39. Cancer. Broad term A group of diseases characterized by uncontrolled cellular growth Invasion into surrounding tissue Metastasis Cancer spreads to other areas in the body. Etiology of Cancer. May be: - PowerPoint PPT Presentation

Citation preview

Page 1: Chapter  39

Antineoplastic Agents and Adjunct Drugs Used in Cancer Treatment

Page 2: Chapter  39

Cancer

Broad term A group of diseases characterized by uncontrolled cellular growth

Invasion into surrounding tissue Metastasis

Cancer spreads to other areas in the body

2

Page 3: Chapter  39

Etiology of Cancer

May be:EnvironmentLifestyleOccupationGenetic and ethnic factors

Age- and sex-related differences

3

Page 4: Chapter  39

Cell Growth Cycle

Normal cells and cancer cells go through five distinct growth phase cycles

-G0 -resting cycle -G1 -first growth -S –DNA synthesis phase -G2 –second growth -M1 -mitosis phase Cancer cells divide rapidly

4

Page 5: Chapter  39

Treatment Considerations

Growth Fraction -The fraction of cells that are in active phases Mitotic index -Percentage of cell undergoing

mitosis Antineoplastics most effective when

the growth fraction and mitotic index are high

5

Page 6: Chapter  39

Treatment Considerations

Cancer stage when it is discovered

Efficacy of the cancer treatment

Development of drug resistance

General health of the client6

Page 7: Chapter  39

Antineoplastics

Divided into two groups -Cell cycle nonspecific (CCNS) -Cell cycle specific (CCS) CCNS effective against slow-

growing cancer cells CCS effective against fast-

growing cancer cells

7

Page 8: Chapter  39

Agents Used in the Treatment of Cancer Alkylating agents Antimetabolites Mitotic inhibitors Antibiotics Hormones

8

Page 9: Chapter  39

Agents used in the Treatment of Cancer

Radioactive drugs Biological response modifiers Miscellaneous agents Combination therapy Adjuvant agents

9

Page 10: Chapter  39

Agents Used in the Treatment of Cancer Alkylating agents: cell cycle

nonspecific Antimetabolites: cell cycle

specific in the S phase Mitotic inhibitors: cell cycle

specific in the M phase

10

Page 11: Chapter  39

Antineoplastic Agents

Affect all cells, both healthy and sick

Dose-limiting effects Hair falls out Cells in the gastrointestinal tract

die Nausea and vomiting occur;

emetic potential Myelosuppression

Nadir: lowest point for the bone marrow cells, WBCs, platelets

11

Page 12: Chapter  39

Antineoplastics: Adverse/Side Effects Common

Fever, chills, headache, nausea, and vomiting

Serious Bronchospasm, dyspnea, hypotension, and angioedema

12

Page 13: Chapter  39

Combination Therapy

Use of several antineoplastic agents at the same time

Proven effectiveness Rationale of using combination

therapy Have a more beneficial effect than when used alone

Each agent exhibits different actions and toxicities 13

Page 14: Chapter  39

Adjuvant Agents

Antiemetics Ondansetron HCl (Zofran)

Appetite Stimulants Megace ES (megestrol acetate) Marinol (THC)

Blood cell-forming agents Epoetin alfa (Procrit) Neulasta

14

Page 15: Chapter  39

Nursing Implications

During administration of the antineoplastic:

-Provide significant hydration to prevent nephrotoxicity

-Provide periodic monitoring of heart and lung function

15

Page 16: Chapter  39

Nursing Considerations

Obtain thorough health history and physical assessment

Assess support systems Provide for expression of feelings Provide education regarding illness

and treatment regimen Pain control Assessment of the patient’s

emotional status

16

Page 17: Chapter  39

Nursing considerations

Monitoring of labs, fluid and electrolyte balance

Nutritional evaluation Address infection status and

education Provide for safety needs Be alert for adverse effects of the

drugs Ongoing assessment is crucial

17

Page 18: Chapter  39

Adverse Effects: Chemotherapy Risk for infection

Risk for bleeding Risk for ineffective tissue perfusion Nausea and vomiting Risk for vesicant extravasation Body image disturbances Uric acid neuropathy Hemorrhagic cystitis Pain

18

Page 19: Chapter  39

Handling of Cytotoxic Drugs

Be familiar with institution policies and procedures

Use proper protective equipment

Do not handle if pregnant

19

Page 20: Chapter  39

Handling of Cytotoxic Drugs Take all special precautions Contaminated material must

be disposed of properly Spill kit Follow proper procedures for

exposure

20

Page 21: Chapter  39

Investigational Drugs

Written prescription

Signed consent Drug information

available Follow research

protocol Keep thorough

records

21

Page 22: Chapter  39

Patient Teaching Provide education regarding cancer

and treatment Emphasize importance of following

chemotherapy regimen Teaching regarding central venous

catheters Education regarding signs and

symptoms to report to provider Address appropriateness of home

care22

Page 23: Chapter  39

Legal and Ethical Principles

To avoid errors Standardized, preprinted

order forms

23